A. Malyshkin

Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain – relation to brain concentration

W. Danysz, A. Jirgensons, I. Belozertseva, 2006, Neuropharmacology.

Facilitation of electrical brain self-stimulation behavior by abused solvents

E. Zvartau, I. Belozertseva, I. Sukhotina, 2003, Pharmacology Biochemistry and Behavior.

The anxiolytic and analgesic properties of fenobam, a potent mGlu5 receptor antagonist, in relation to the impairment of learning

W. Jacob, W. Danysz, I. Belozertseva, 2009, Neuropharmacology.

Anti-allodynic interactions between NMDA receptor channel blockers and morphine or clonidine in neuropathic rats.

W. Danysz, A. Bespalov, A. Malyshkin, 2005, European journal of pharmacology.

Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain

C. Parsons, W. Danysz, E. Zvartau, 2004, Neuropharmacology.

Lack of depression-like effects of saccharin deprivation in rats: forced swim test, differential reinforcement of low rates and intracranial self-stimulation procedures.

A. Markou, I. Sukhotina, A. Bespalov, 2003, Behavioral neuroscience.

Comparison of the mGluR1 antagonist A-841720 in rat models of pain and cognition

W. Schmidt, W. Danysz, I. Belozertseva, 2007, Behavioural pharmacology.

The NMDA receptor channel blocker memantine and opioid receptor antagonist naltrexone inhibit the saccharin deprivation effect in rats

W. Danysz, I. Sukhotina, A. Bespalov, 2004, Behavioural pharmacology.